Lesinidase alfa Uses, Dosage, Side Effects and more
Lesinidase alfa is under investigation in clinical trial NCT02324049 (Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB)).
Trade Name | Lesinidase alfa |
Generic | Lesinidase alfa |
Lesinidase alfa Other Names | Lesinidase alfa |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |